These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2019628)

  • 1. Myocardial protection with Hamburg oxygenated crystalloid cardioplegic solution for multiple coronary bypass and multivalvular replacement.
    Jegaden O; Girard C; Finet G; Bouvier H; Vial C; Montagna P; Rumolo A; Mikaeloff P
    J Cardiovasc Surg (Torino); 1991; 32(2):233-8. PubMed ID: 2019628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and metabolic evaluation of myocardial protection by oxygenated cardioplegia (Hamburg solution) in multiple coronary bypass surgery or polyvalvular replacement].
    Jegaden O; Vial C; Montagna P; Rumolo A; Bouvier H; Girard C; Mikaeloff P
    Ann Chir; 1989; 43(8):636-41. PubMed ID: 2589799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
    Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
    Tachibana H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
    Coetzee A; Kotzé J; Louw J; Lochner A
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis.
    Braathen B; Tønnessen T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):874-80. PubMed ID: 19660338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time course of myocardial high-energy phosphate degradation during potassium cardioplegic arrest.
    Engelman RM; Rousou JH; Longo F; Auvil J; Vertrees RA
    Surgery; 1979 Jul; 86(1):138-47. PubMed ID: 572100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of crystalloid cardioplegic solutions in patients undergoing myocardial revascularization. Effect of infusion route and regional wall motion on preservation of adenine nucleotide stores.
    Silverman NA; Wright R; Levitsky S; Schmitt G; Feinberg H
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):90-6. PubMed ID: 3965820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved myocardial protection with blood and crystalloid cardioplegia.
    Weisel RD; Fremes SE; Baird RJ; Ivanov J; Madonik MM; Mickle DA
    J Vasc Surg; 1984 Sep; 1(5):656-9. PubMed ID: 6389911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
    Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
    Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
    Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
    Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
    J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of exogenous creatine phosphate for myocardial protection in patients undergoing coronary artery bypass surgery.
    Cisowski M; Bochenek A; Kucewicz E; Wnuk-Wojnar AM; Morawski W; Skalski J; Grzybek H
    J Cardiovasc Surg (Torino); 1996 Dec; 37(6 Suppl 1):75-80. PubMed ID: 10064355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution.
    Guyton RA; Dorsey LM; Craver JM; Bone DK; Jones EL; Murphy DA; Hatcher CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):877-87. PubMed ID: 3873582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of myocardial function and biochemistry after blood and oxygenated crystalloid cardioplegia during cardiac arrest.
    Coetzee A; Roussouw G; Fourie P; Lochner A
    Ann Thorac Surg; 1990 Aug; 50(2):230-7. PubMed ID: 2383108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. St. Thomas' Hospital cardioplegia: enhanced protection with exogenous creatine phosphate.
    Chambers DJ; Haire K; Morley N; Fairbanks L; Strumia E; Young CP; Venn GE
    Ann Thorac Surg; 1996 Jan; 61(1):67-75. PubMed ID: 8561641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial protection during prolonged ischaemic cardiac arrest: experimental evaluation of three crystalloid cardioplegic solutions.
    Chong YS; Cottier DS; Gavin JB
    J Cardiovasc Surg (Torino); 1994 Feb; 35(1):35-44. PubMed ID: 8120076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.